Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection

Infection Control and Hospital Epidemiology

Volumn 30, Issue 4, 2009, Pages 325-331

  Pop Vicas, Aurora ^a   Tacconelli, E ^e   Gravenstein, Stefan ^c   Bing, Lu ^b   D'Agata, Erika M C ^d  

^a Division of Infectious Diseases   (United States)

^b Research Center for Primary Care and Prevention Memorial Hospital of RI   (United States)

^c BROWN UNIVERSITY   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN;

AGED; AGED HOSPITAL PATIENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CONTROLLED STUDY; DEVICE INFECTION; DISEASE ASSOCIATION; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; KLEBSIELLA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS MIRABILIS; RISK ASSESSMENT; SEPSIS; TERTIARY HEALTH CARE; THERAPY DELAY; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BOSTON; CASE-CONTROL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; PATIENT ADMISSION; PREVALENCE; RISK FACTORS;

EID: 63449093245     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/596608     Document Type: Article

References (35)

1. Blot S, Vandewoude K, De Bacquer D, et al. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002; 34:1600-1606.
2. Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34:15-21.
3. Jones RN. Resistance patterns among nosocomial pathogens: trend over the past years. Chest 2001; 119(S2):397S-404S.
4. Flournoy DJ, Reinert RL, Bell-Dixon C, et al. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units. Am J Infect Control 2000; 28:244-250.
5. D'Agata EMC. Rapidly rising prevalence of nosocomial multidrug-resistant, gram-negative bacilli: a 9-year surveillance study. Infect Control Hasp Epidemiol 2004; 25:842-846.
6. Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Trends in antimicrobial susceptibilities among Enterobacteriaceae isolates from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother 2003; 47:1672-1680.
7. National Noscomial Infections Surveillance System 2004. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
8. O'Fallon E, Pop-Vicas A, D'Agata EMC. The emerging threat of multi-drug resistant gram-negative organisms in a long-term care facilities. J Gerontol A Biol Sci Med Sci 2009 (in press).
9. Pop-Vicas AE, D'Agata EM. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital. Clin Infect Dis 2005; 40: 1792-1798.
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes J. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
11. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37:230-237.
12. Paterson DL, Ko WC, Von Gottberg S, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140:26-32.
13. Charlson M, Pompei P, Ales K, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40:373-383.
14. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: supplement M100-S16. Wayne, PA: CLSI, 2006.
15. Pfaller MA, Segreti J. Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clin Infect Dis 2006; 42(suppl 4):S153-S163.
16. Opal SM, Girard TD, Ely WE. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005; 41:S504-S512.
17. Harbarth S, Garbino J, Pugin J, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-535.
18. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31:2742-2751.
19. Peralta G, Sanchez MB, Garrido JC, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother 2007; 60: 855-863.
20. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
21. Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281:517-523.
22. Trick W, Weinstein RA, DeMarais PL, et al. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc 2001;49:270-276.
23. Bonomo, R. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis 2000; 31:1414-1422.
24. Nicolle LE. Preventing infections in non-hospital settings: long-term care. Emerg Infect Dis 2001; 7:205-207.
25. Loeb M, Simor AE, Landry L, et al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med 2001; 16:376-383.
26. Warren JW, Palumbo FB, Fitterman L, Speedie SM. Incidence and characteristics of antibiotic use in aged nursing home patients. J Am Geriatr Soc 1991; 39:963-972.
27. Zimmer JG, Bentley DW, Valenti WM, et al. Systemic antibiotic use in nursing homes: a quality assessment. J Am Geriatr Soc 1986; 34:703-710.
28. Pickering TD, Gurwitz JH, Zaleznik D, et al. The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting. J Am Geriatr Soc 1994; 42:28-32.
29. Jones SR, Parker DF, Liebow ES, et al. Appropriateness of antibiotic therapy in long-term care facilities. Am J Med 1987; 83:499-502.
30. D'Agata EMC, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008; 168:357-362.
31. Pop-Vicas A, Strom T, D'Agata EMC. Multidrug-resistant gram-negative bacilli among patients who require chronic hemodialysis. Clin J Am Soc Nephrol 2008; 3:752-758.
32. Nicolle LE, Bentley D, Garibaldi R, et al. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 1996; 17:119-128.
33. D'Agata EMC. Methodological issues of case-control studies: a review of established and newly recognized limitations. Infect Control Hosp Epidemiol 2005; 26:338-341.
34. Falagas M, Koletsi P, Bliziotis I. The diversity of definitions of multidrugresistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006; 55:1619-1629
35. Harris AD, Samore MH, Lipsitch M, et al. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. Clin Infect Dis 2002; 34:1558-1563.